Is HLA-DQ2 useful for Blutzucker?

HLA-DQ2 is a genetic marker primarily associated with celiac disease, not directly with blood sugar. A positive result increases risk for gluten intolerance, which can indirectly affect blood glucose through intestinal inflammation, malabsorption, and altered incretin signaling. However, evidence for a direct utility in blood sugar management is weak and only mechanistic. No robust human studies show that HLA-DQ2 alone predicts or explains glycemic variability or diabetes risk. It may be relevant if celiac disease is suspected (e.g., unexplained hypoglycemia or postprandial glucose swings), but only as part of a full diagnostic workup. MyBody-X does not list HLA-DQ2 in its test panels; their DNA tests focus on metabolism, longevity, and nutrient genes. Consumers should not use HLA-DQ2 for diabetes screening or blood sugar optimization. Safety note: Always consult a physician for blood sugar concerns; rely on validated biomarkers like HbA1c, fasting glucose, and OGTT.